Evaluating Vitamin D levels in Rheumatic Heart Disease patients and matched controls: A case-control study from Nepal

Lene Thorup1,2, Sophie Amalie Hamann2, Ashish Tripathee3

  • 1Department of Cardiothoracic & Vascular Surgery, Aarhus University Hospital, Skejby, Aarhus, Denmark.

Plos One
|August 22, 2020
PubMed

Insights

Rheumatic Heart Disease (RHD) patients in Nepal show lower Vitamin D levels and poorer nutritional status. Vitamin D insufficiency is linked to a higher risk of developing RHD.

Area of Science:

  • Cardiology
  • Nutritional Science
  • Immunology

Background:

  • Rheumatic Heart Disease (RHD) affects millions globally, particularly in low-income countries, with limited access to diagnosis and treatment.
  • Understanding RHD risk factors and disease mechanisms is crucial for prevention and improved treatment strategies.
  • This study specifically investigated the role of Vitamin D deficiency, known for its immunomodulatory effects, as a potential risk factor for RHD in Nepal.

Purpose of the Study:

  • To investigate risk factors associated with Rheumatic Heart Disease (RHD) in a Nepalese population.
  • To examine the specific association between Vitamin D deficiency and RHD.
  • To evaluate the nutritional status of RHD patients compared to healthy controls.

Main Methods:

  • Recruited 99 RHD patients and 97 healthy controls from Nepalese hospitals.
  • Assessed serum 25(OH)D concentrations using dried blood spots and measured anthropometric values.
  • Employed conditional logistic regression analysis to determine the link between Vitamin D deficiency and RHD.

Main Results:

  • RHD patients exhibited lower mean Vitamin D levels (39 nmol/l) compared to controls (45 nmol/l).
  • Vitamin D insufficiency was associated with a 2.59 times higher risk of RHD (OR = 2.59; 95% CI: 1.04-6.50).
  • RHD patients had significantly lower Body Mass Index (BMI) than controls, indicating poorer nutritional status.

Conclusions:

  • Nepalese RHD patients demonstrate lower Vitamin D levels and compromised nutritional status compared to non-RHD individuals.
  • Further longitudinal studies are required to establish causality between RHD and Vitamin D levels.
  • Research is recommended to confirm the widespread low Vitamin D levels observed in the general Nepalese population.
Abstract

Related Concept Videos

Connective Tissue Cell Types01:22

Connective Tissue Cell Types

Connective tissue develops from the mesoderm of a developing embryo and consists of cells, fibers, and ground substance: a gel-like material containing large complexes of carbohydrates and proteins. Connective tissue was first identified as a separate tissue family in the 18th century, and Johannes Peter Muller coined the term connective tissue.
Fat cells (adipocytes), smooth muscle cells (myoblasts), and bone cells (osteoblasts) are some connective tissue cell types. Some immune system cells...
Rheumatic Heart Disease I: Introduction01:23

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
Rheumatic Heart Disease III: Medical Management01:21

Rheumatic Heart Disease III: Medical Management

Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
Rheumatic Heart Disease IV: Nursing Management01:20

Rheumatic Heart Disease IV: Nursing Management

AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...